https://www.selleckchem.com/products/gs-9973.html
03, 95% CI 1.02-1.06), T4 disease (OR 3.34, 95% CI 1.05-10.68), and treatment at a community center (OR 2.92, 95% CI 1.58-5.4. Overall median survival was significantly poorer for NS patients (50.4 versus 78.4 months, P 0.01). Patients with locally advanced ACC are less likely to undergo an operation, while those treated at centers with more operative experience or Academic facilities are more likely to undergo an operation. As the surgery-first approach is the current standard of care for resectable ACC, these patients may be be
Like
Comment
Share
